Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 5Phase 1 4Phase EARLY_PHASE1 2Phase 1/2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Fallopian Tube Neoplasms 2Successful Conversion Rate of Operation 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

X-Rays 2Platinum 2Magnetic Resonance Spectroscopy 2Hyperthermic Intraperitoneal Chemotherapy 2Drug Therapy 2Cytoreduction Surgical Procedures 2Cisplatin 2Aspirin 21,2-diaminocyclohexaneplatinum II citrate 2talazoparib 1sodium thiosulfate 1propranolol CR 1pembrolizumab 1olaparib 1epacadostat 1adavosertib 1Taxes 1Specimen Handling 1Propranolol 1Paclitaxel 1Ketorolac Tromethamine 1Ketorolac 1Fluoresceins 1Fluorescein 1Doxorubicin 1Carboplatin 1Auranofin 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Fallopian Tube Neoplasms × Drug Therapy × Clear all
NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01504126 2019-08-29

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
32 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡